As Q1 2025 comes to a close, Dutch tech has a strong year behind it.
According to the fifth edition of the State of Dutch Tech report by Techleap, Dutch tech companies raised €3.1B in venture capital over the past year, a 47 per cent increase compared to the previous year.
With major funding rounds closing across various industries, it’s an exciting time for innovation in the Netherlands.
Some of these startups aren’t just making waves—they’re also hiring fresh talent to sustain their momentum.
Today, we present a selection of nine notable funding rounds announced in Q1 2025. Six of the companies were hiring when this article was published. Check them out below.
Mews
HQ: Amsterdam
Fund raised in Q1, 2025: €70.6M
CEO: Matt Welle
Hiring: Yes| Apply here
Mews has developed Mews Hospitality Cloud to streamline operations for modern hoteliers, transform the guest experience, and create more profitable businesses.
The Dutch company’s clients include BWH Hotels, Strawberry, The Social Hub, and Airelles Collection. The company claims to have over 5,500 customers across more than 85 countries.
Leyden Labs
HQ: Leiden
Fund raised in Q1, 2025: €68M
Founder/s: Jaap Goudsmit, Koenraad Wiedhaup, and Ronald Brus
Hiring: Yes| Apply here
Leyden Labs works to free people from the threat of respiratory viruses. The company utilises its platform to target commonalities of viral families to protect against many viruses simultaneously, as opposed to vaccines that typically protect against a specific virus variant.
The Dutch company’s platform is built on two concepts: broad protection against known viruses, new variants, and newly emerging viruses, and protection at the gate, i.e., in the mucosa (e.g., in the nose and throat).
Alesta Therapeutics
HQ: Leiden
Fund raised in Q1, 2025: €65M
CEO: Ilan Ganot
Hiring: No
Alesta Therapeutics is a biotechnology company developing transformative small-molecule therapies for rare diseases.
The Dutch company focuses on creating novel oral treatments for underserved conditions. Its lead asset, ALE1, targets hypophosphatasia (HPP), while ALE2 is aimed at treating Charcot-Marie-Tooth (CMT) disease.
Piano
HQ: Amsterdam
Fund raised in Q1, 2025: €111M
Founder/s: Trevor Kaufman
Hiring: Yes| Apply here
Piano.io is a digital experience platform that helps media businesses optimise user engagement and drive revenue.
Its Digital Experience Cloud offers AI-driven recommendations, automation, and personalised journeys to boost conversions for publishers, broadcasters, and content creators.
The Dutch company operates on a subscription-based model, providing continuous updates and white-labeled solutions for integration.
With open APIs and easy integrations, Piano.io enables businesses to enhance customer interactions efficiently while maximising subscriptions, conversions, and analytics.
The company secured a total financing of $120M (approximately €111M), which includes a $75M (approximately €70M) senior secured term loan facility, led by Runway Growth Capital LLC.
The package also includes a $45M (approximately €41.7M) Series D investment led by Updata Partners, a Washington, D.C.-based growth equity firm focused on technology.
Vivici
HQ: Delft
Fund raised in Q1, 2025: €32M
CEO: Stephan van Sint Fiet
Hiring: No
Vivici is a B2B ingredients company pioneering the development of superior dairy proteins through precision fermentation.
Backed by nutrition, health, and beauty multinational dsm-firmenich and dairy multinational Fonterra, Vivici uses precision fermentation to create dairy protein.
This method blends traditional fermentation with modern biotechnology to produce proteins without involving animals. Vivitein BLG, an isolated whey protein (beta-lactoglobulin), is the first ingredient to be launched under the company’s ViviteinTM protein platform.
Quantware
HQ: Delft
Fund raised in Q1, 2025: €20M
Founder/s: Alessandro Bruno and Matthijs Rijlaarsdam
Hiring: Yes| Apply here
QuantWare develops quantum hardware, including VIO, a technology for scaling up large quantum processors (QPUs). The Dutch company supports quantum computing systems in 20 countries across four continents.
VIO enables scaling for any qubit design and provides a pathway toward systems with more than 1 million qubits. The technology is available in fully packaged QPUs and through Foundry and Packaging Services.
Thorizon
HQ: Amsterdam
Fund raised in Q1, 2025: €20M
Founder/s: Sander de Groot and Lucas Pool
Hiring: Yes| Apply here
Thorizon is developing Thorizon One, a modular molten salt reactor designed to use recycled nuclear fuel to produce carbon-free energy. Its proposed core consists of multiple fully enclosed ‘cartridges,’ which could be replaced to incorporate innovations.
The reactor design aims to reduce long-lived radioactive waste and provide 250MW of thermal power, equivalent to approximately 110MW of electrical output. These are design targets: the company’s March 2025 announcement described design and prototype work, with reactor construction planned to begin around 2030.
Workwize
HQ: Amsterdam
Fund raised in Q1, 2025: €12.6M
Founder/s: Michiel Meyer, Victor Dik, Sebastiaan Scholten, and Dirk Kranendijk
Hiring: Yes|Apply here
Workwize simplifies IT hardware management for globally distributed teams, automating procurement, deployment, retrieval, and disposal.
The platform reduces IT hardware administrative time per employee from hours to minutes, offering zero-touch, end-to-end lifecycle management supported by a global vendor network.
Sirius Medical
HQ: Eindhoven
Fund raised in Q1, 2025: €10M
CEO: Bram Schermers
Hiring: No
Sirius Medical aims to improve care for cancer patients by delivering solutions that enable the precise and efficient removal of tumours.
The company’s Pintuition technology provides surgeons real-time distance and directional navigational guidance to locate tumours accurately.
The Sirius Pintuition surgical navigation platform enables simple, best-in-class wire-free localisation for breast-conserving surgery in any hospital.
